Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
Letter to the Editor.
Neuropathic pruritus (itch) in neuromyelitis optica.
Environment may play significant role in multiple sclerosis.
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
Oral laquinimod for multiple sclerosis.
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study.
Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function.
Remyelination after Lysophosphatidyl Choline-Induced Demyelination Is Stimulated by Bone Marrow Stromal Cell-Derived Oligoprogenitor Cell Transplantation.
Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis.
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Xavier Montalban: a pioneer in understanding multiple sclerosis.
History, applications, and mechanisms of deep brain stimulation.
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function, and macular thickness in healthy volunteers.
Do people with and without medical conditions respond similarly to the Short Health Anxiety Inventory? An assessment of differential item functioning using item response theory.
Methods and measures: what's new for MS?
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.
AB Science announces successful non futility test for masitinib in progressive forms of multiple sclerosis
Pages
« first
‹ previous
…
235
236
237
238
239
240
241
242
243
…
next ›
last »